Biofrontera (BFRIW) Competitors $0.11 +0.05 (+94.35%) As of 02/21/2025 03:59 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsSEC FilingsShort InterestTrends BFRIW vs. ATNFW, LBPSW, AARD, AEHAW, AIMDW, ALVOW, ACABW, BTMDW, BCTXW, and CELUWShould you be buying Biofrontera stock or one of its competitors? The main competitors of Biofrontera include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aardvark Therapeutics (AARD), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Atlantic Coastal Acquisition Corp. II (ACABW), biote (BTMDW), BriaCell Therapeutics (BCTXW), and Celularity (CELUW). These companies are all part of the "pharmaceutical products" industry. Biofrontera vs. 180 Life Sciences 4D pharma Aardvark Therapeutics Aesther Healthcare Acquisition Ainos Alvotech Atlantic Coastal Acquisition Corp. II biote BriaCell Therapeutics Celularity Biofrontera (NASDAQ:BFRIW) and 180 Life Sciences (NASDAQ:ATNFW) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their media sentiment, community ranking, institutional ownership, analyst recommendations, dividends, profitability, valuation, risk and earnings. Does the MarketBeat Community prefer BFRIW or ATNFW? Biofrontera and 180 Life Sciences both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformBiofronteraN/AN/A180 Life SciencesN/AN/A Does the media refer more to BFRIW or ATNFW? In the previous week, 180 Life Sciences had 1 more articles in the media than Biofrontera. MarketBeat recorded 1 mentions for 180 Life Sciences and 0 mentions for Biofrontera. 180 Life Sciences' average media sentiment score of 1.38 beat Biofrontera's score of 0.00 indicating that 180 Life Sciences is being referred to more favorably in the news media. Company Overall Sentiment Biofrontera Neutral 180 Life Sciences Positive Is BFRIW or ATNFW more profitable? Company Net Margins Return on Equity Return on Assets BiofronteraN/A N/A N/A 180 Life Sciences N/A N/A N/A Which has higher valuation and earnings, BFRIW or ATNFW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBiofrontera$35.36MN/AN/AN/AN/A180 Life SciencesN/AN/AN/AN/AN/A Summary180 Life Sciences beats Biofrontera on 2 of the 3 factors compared between the two stocks. Get Biofrontera News Delivered to You Automatically Sign up to receive the latest news and ratings for BFRIW and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BFRIW vs. The Competition Export to ExcelMetricBiofronteraDrug Manufacturers IndustryMedical SectorNASDAQ ExchangeMarket CapN/A$2.35B$5.84B$9.14BDividend YieldN/A2.92%4.75%3.85%P/E RatioN/A4.2726.0419.11Price / SalesN/A733.09447.4676.36Price / CashN/A10.2538.0134.83Price / BookN/A7.507.644.62Net IncomeN/A$20.70B$3.18B$245.85M7 Day PerformanceN/A-0.04%-2.00%-2.61%1 Month PerformanceN/A0.08%-0.44%-2.14%1 Year PerformanceN/A98.03%16.44%12.98% Biofrontera Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BFRIWBiofronteraN/A$0.11+94.3%N/A+254.1%$0.00$35.36M0.0070Gap UpHigh Trading VolumeATNFW180 Life SciencesN/A$0.01-6.1%N/A+51.5%$0.00N/A0.007News CoveragePositive NewsGap DownLBPSW4D pharmaN/AN/AN/AN/A$0.00$522,000.000.00N/AAARDAardvark TherapeuticsN/A$13.35+0.4%N/AN/A$0.00N/A0.0018Insider TradeNews CoverageAEHAWAesther Healthcare AcquisitionN/A$0.03-7.4%N/A-13.4%$0.00N/A0.002Gap UpAIMDWAinosN/A$0.12-9.4%N/A+138.5%$0.00$40,633.000.0040Gap UpALVOWAlvotechN/A$2.50+2.0%N/A-46.2%$0.00$391.87M0.004Gap UpACABWAtlantic Coastal Acquisition Corp. IIN/A$0.05-16.9%N/A-54.4%$0.00N/A0.004BTMDWbioteN/A$0.53+5.8%N/A-46.2%$0.00$193.06M0.00N/AGap DownBCTXWBriaCell TherapeuticsN/A$0.13+10.4%N/A-92.9%$0.00N/A0.008Gap UpHigh Trading VolumeCELUWCelularityN/A$0.07+14.4%N/A+120.8%$0.00$48.20M0.00220 Related Companies and Tools Related Companies 180 Life Sciences Competitors 4D pharma Competitors Aardvark Therapeutics Competitors Aesther Healthcare Acquisition Competitors Ainos Competitors Alvotech Competitors Atlantic Coastal Acquisition Corp. II Competitors biote Competitors BriaCell Therapeutics Competitors Celularity Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:BFRIW) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersNvidia’s Next Big Move Comes on Feb. 26Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of ...Weiss Ratings | SponsoredA strange twist 500 miles from WashingtonEnergy is life. And this year, it could also make national heroes out of President Trump and VP Vance. ...Porter & Company | SponsoredMajor AI announcement for 2025BIG NEWS: “Market Wizard” Larry Benedict Releases a Whole New Way to Trade AI StocksBrownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biofrontera Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Biofrontera With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
